QUOTIENT SCIENCES LIMITED (05221615) is a private limited company registered in NOTTINGHAM, incorporated in 2004. The company operates in the research and experimental development on biotechnology sector. With 110 data signals collected from 16 government and public sources, QUOTIENT SCIENCES LIMITED has one of the more comprehensive data profiles in our database. Risk assessment: 88/100 ("robust"), reflecting a strong compliance and financial profile. The company has 2 outstanding mortgage charges registered with Companies House.
QUOTIENT SCIENCES LIMITED is an active private limited company incorporated in 2004 in Nottingham, specializing in research and experimental development on biotechnology. Its website highlights services as a pharmaceutical CRDMO offering small molecule drug development, Phase 1 clinical trials, and drug manufacturing with a focus on data-driven solutions.
Extensive data coverage from 16 government and public sources. Risk score of 88 indicates a strong compliance profile.
QUOTIENT SCIENCES LIMITED is 1 of 53 research and experimental development on biotechnology companies in NOTTINGHAM, out of 4,024 active companies in this sector nationally (4,909 including dissolved).
QUOTIENT SCIENCES LIMITED is listed as the proprietor of 8 properties in the HM Land Registry.
Properties are located in East Midlands, South East.
QUOTIENT SCIENCES LIMITED pays invoices in an average of 36 days. 37% are paid within 30 days.
This company profile is built from 14 official data sources: Ch Officers, Companies House, Environment Agency, GLEIF, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, Modern Slavery Registry, Payment Practices, SBTi, The Gazette, Uk Trade Info.
QUOTIENT SCIENCES LIMITED is an active private limited company incorporated in 2004 in Nottingham, specializing in research and experimental development on biotechnology.
Current directors include MR DESMOND KENNETH NEIL GLASS, MR THIERRY ANDRE VAN NIEUWENHOVE, MRS VICTORIA ALICE HUSTLER.
QUOTIENT SCIENCES LIMITED is registered in NOTTINGHAM, United Kingdom.
QUOTIENT SCIENCES LIMITED operates under SIC code 72110 — Research and experimental development on biotechnology.
QUOTIENT SCIENCES LIMITED has a risk score of 88 out of 100, classified as "Robust". This score is calculated from 110 data signals across 16 government sources.
The next accounts for QUOTIENT SCIENCES LIMITED are due on 31 Dec 2026.
Yes, QUOTIENT SCIENCES LIMITED was previously known as QUOTIENT CLINICAL LIMITED, PHARMACEUTICAL PROFILES GROUP LIMITED, INGLEBY (1619) LIMITED.
QUOTIENT SCIENCES LIMITED offers Pharmaceutical CRDMO, Small Molecule Drug Development, Phase 1 Clinical Trials, Drug Manufacturing, Clinical Research.
Yes, QUOTIENT SCIENCES LIMITED is listed as the proprietor of 8 properties in the HM Land Registry, located in East Midlands, South East.
The dissolution rate for the research and experimental development on biotechnology sector in the UK is 12.2%. The average company age in this sector is 7.2 years.
QUOTIENT SCIENCES LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
QUOTIENT SCIENCES LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
QUOTIENT SCIENCES LIMITED was incorporated on 3 Sept 2004, making it 22 years old. The company remains active and in good standing.
QUOTIENT SCIENCES LIMITED is classified under SIC code 72110 (Research and experimental development on biotechnology). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 110 data signals from 16 official government sources for QUOTIENT SCIENCES LIMITED.